1. Medtech Insight

Minute Insight: Thread Buys CureClick To Promote Participation In Clinical Trials

 
• By Reed Miller

CureClick has developed the first “crowdsourcing” platform to accelerate awareness of and participation in clinical trials, which will help trial leaders reach traditionally underrepresented patient populations.

Minute Insight
• Source: Informa/Alamy

Thread continues to grow its decentralized trials platform through acquisitions.

The North Carolina-based technology and consulting company is focused exclusively on supporting decentralized clinical trials, which rely on telehealth, remote...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

US FDA Unveils Plans To Consolidate Support Services

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.

A Year After Exiting The Ventilator Market, Medtronic Recalls Thousands Of Newport Devices

 
• By Brian Bossetta

After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.

‘UK Must Put Adoption On A Par With Innovation’

 
• By Ashley Yeo

Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.